Skip to main content

Table 4 Acute period outcomes (28 days following index): patients with severe renal disease and active cancer

From: Characteristics and outcomes of COVID-19 patients presumed to be treated with sotrovimab in NHS hospitals in England

Outcome

Severe renal disease

(n = 1422)

Active cancer

(n = 910)

COVID-19-attributable hospitalization, n (%)

18 (1.3)

10 (1.1)

Any-cause hospitalization, n (%)

97 (6.8)

89 (9.8)

All-cause deaths, n (%)

4 (0.3)

7 (0.8)

  1. COVID-19, coronavirus disease 2019